Analyst Recommendations

0.95 0.06(6.48%)10/04/2024
Adaptimmune Therapeutics Plc (ADAP)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy3

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades